As the demand for peptide-based therapeutics continues to grow, the need for innovative, cost-efficient, and environmentally friendly manufacturing…

  Linear synthesis by continuous-flow SPOS is the current state-of-the-art technology to manufacture oligonucleotide APIs. A very promising alternative,…

Oligonucleotide-based therapeutics are transforming modern medicine, offering targeted solutions for genetic disorders, cancer, cardiovascular disease, and CNS conditions.…

  Linear synthesis by continuous-flow SPOS is the current state-of-the-art technology to manufacture oligonucleotide APIs. A very promising…

Peptides have the potential to expand the space of “druggable” targets. No wonder the number of them being under…

Discover how Bachem revolutionized the production of octreotide acetate, a critical therapeutic peptide used in treating acromegaly. Our…

Resembling a new era of innovative drug development, the interest of the biopharma industry in the oligonucleotide markets…

Resembling a new era of innovative drug development, the interest of the biopharma industry in the peptide and…